<DOC>
	<DOCNO>NCT00629551</DOCNO>
	<brief_summary>The main purpose study evaluate efficacy saredutant 100mg 30mg daily combination paroxetine 20mg daily compare saredutant placebo combination paroxetine 20mg daily patient major depressive disorder . The study also include double-placebo group ( saredutant placebo combination paroxetine placebo ) .</brief_summary>
	<brief_title>An Eight-week Study Saredutant Paroxetine Combination Treatment Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Outpatients recurrent Major Depressive Disorder Symptoms current depressive episode less 30 day 2 year Mild depression , measure standard clinical research scale Significant suicide risk Lack sexual activity ( include masturbation ) Other psychiatric condition would obscure result study History failure respond antidepressant treatment Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Episode</keyword>
	<keyword>Antidepressant</keyword>
</DOC>